
Opinion|Videos|October 12, 2023
Integrating MRI and Ultrasound Fusion-Based Technology for Personalized Focal Therapy in Prostate Cancer
Author(s)Amir H. Lebastchi, MD
Dr. Amir H. Lebastchi elaborates on his approach to integrating MRI and ultrasound fusion-based technology for guiding treatment selection and tailoring therapy for patients with prostate cancer.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Study shows durable 3-year outcomes with first-line gemcitabine/docetaxel in NMIBC
2
Kathryn Gessner, MD, PhD, on the challenges of selecting patients for bladder preservation
3
Experts discuss the challenge of detecting CIS in bladder cancer
4
First-in-human bladder transplant demonstrates sustained function at 6 months
5













